We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




A New Tissue Scaffold Helps Cartilage and Bone Grow

By HospiMedica International staff writers
Posted on 26 May 2009
A new tissue scaffold that can stimulate bone and cartilage growth when transplanted into the knees or other joints could offer a potential new treatment for sports injuries and other cartilage damage, such as arthritis. More...


Researchers at MIT (Cambridge, MA, USA) and Cambridge University (United Kingdom) developed the triple coprecipitated collagen, glycosaminoglycan, and calcium phosphate (CGCaP) nanocomposites scaffold, which has two layers, one that mimics bone and one that mimics cartilage. To mimic the structure of bone, the researchers began with collagen (from a bovine tendon source) and glycosaminoglycan mixture; to mineralize the resulting collagen scaffold, the researchers than added the sources of calcium and phosphate. By varying the composition of the CGCaP suspension--thus enabling the production of scaffolds whose architecture was composed of pores of a mean size of 50-1,000 μm and controlling the cross-linking density--the researchers were able to produce a scaffold with a gradual transition between the bone and cartilage layers. When implanted into a joint, the scaffold stimulates mesenchymal stem cells in the bone marrow to produce new bone and cartilage. The technology is currently limited to small defects, using scaffolds roughly eight mm in diameter. The technology has been licensed to Orthomimetics (Cambridge, United Kingdom), which has recently started clinical trials of the scaffold in Europe. The new scaffold was described in a series of articles published in the March 2009 issues of the Journal of Biomedical Materials Research.

"We tried to design it so it's similar to the transition in the body. That's one of the unique things about it," said codeveloper Lorna Gibson, Ph.D., a professor of materials science and engineering at MIT. "If someone had a damaged region in the cartilage, you could remove the cartilage and the bone below it and put our scaffold in the hole."

There are currently several different ways to treat cartilage injuries, including stimulating bone marrow to release stem cells by drilling a hole through the cartilage into the bone; transplanting cartilage and the underlying bone from another, less highly loaded part of the joint; or removing cartilage cells from the body, stimulating them to grow in the laboratory, and reimplanting them.

Related Links:

MIT
Cambridge University
Orthomimetics



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.